Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 19.14
-0.26 (-1.34%)
Jun 9, 2026, 3:04 PM CST
SHE:002262 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, SHE:002262 stock has a consensus rating of "Buy" and an average price target of ¥26.70. The average 1-year stock price forecast is 39.50% higher than the current stock price, while the lowest is ¥23.00 (+20.17%) and the highest is ¥30.00 (+56.74%).
Price Target: ¥26.70 (+39.50%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHE:002262 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
6.39B
from 5.91B
Increased by 8.02%
Revenue Next Year
7.38B
from 6.39B
Increased by 15.52%
EPS This Year
1.16
from 1.05
Increased by 10.48%
EPS Next Year
1.49
from 1.16
Increased by 28.45%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.6B | ||
| Avg | 6.4B | ||
| Low | 6.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.4% | ||
| Avg | 8.0% | ||
| Low | 4.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.16 | ||
| Avg | 1.16 | ||
| Low | 1.16 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.5% | ||
| Avg | 10.5% | ||
| Low | 10.5% |